ID: ALA5267648

Max Phase: Preclinical

Molecular Formula: C44H42ClN9O6S

Molecular Weight: 860.40

Associated Items:

Representations

Canonical SMILES:  Cc1sc2c(c1C)C(c1ccc(Cl)cc1)=N[C@@H](CC(=O)NCCCCNC(=O)c1ccc(CNc3cccc4c3C(=O)N(C3CCC(=O)NC3=O)C4=O)cc1)c1nnc(C)n1-2

Standard InChI:  InChI=1S/C44H42ClN9O6S/c1-23-24(2)61-44-36(23)38(27-13-15-29(45)16-14-27)49-32(39-52-51-25(3)53(39)44)21-35(56)46-19-4-5-20-47-40(57)28-11-9-26(10-12-28)22-48-31-8-6-7-30-37(31)43(60)54(42(30)59)33-17-18-34(55)50-41(33)58/h6-16,32-33,48H,4-5,17-22H2,1-3H3,(H,46,56)(H,47,57)(H,50,55,58)/t32-,33?/m0/s1

Standard InChI Key:  XUUXQUUSZSAMLH-JEFWXSHNSA-N

Associated Targets(Human)

MM1.S 1111 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

MV4-11 7307 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Cereblon/Bromodomain-containing protein 4 275 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 860.40Molecular Weight (Monoisotopic): 859.2667AlogP: 5.53#Rotatable Bonds: 13
Polar Surface Area: 196.85Molecular Species: NEUTRALHBA: 12HBD: 4
#RO5 Violations: 3HBA (Lipinski): 15HBD (Lipinski): 4#RO5 Violations (Lipinski): 3
CX Acidic pKa: 11.59CX Basic pKa: 4.44CX LogP: 4.82CX LogD: 4.82
Aromatic Rings: 5Heavy Atoms: 61QED Weighted: 0.09Np Likeness Score: -0.97

References

1. Ding M, Shao Y, Sun D, Meng S, Zang Y, Zhou Y, Li J, Lu W, Zhu S..  (2023)  Design, synthesis, and biological evaluation of BRD4 degraders.,  78  [PMID:36563515] [10.1016/j.bmc.2022.117134]

Source